drugset / Trial / NCT02250976

The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca

NCT02250976

Phase 1 Completed 41 enrolled Hanlim Pharm. Co., Ltd.
RandomizedCrossoverOpen-labelOther

Summary

To evaluate the comparative pharmacokinetics and safety of fixed-dose combination versus coadministration of Lipilfen cap.160mg(micronized fenofibrate160mg) and Livalo tab. 2mg(pitavastatin Ca 2mg) under fed condition in healthy male volunteers.

Timeline

Start
2014-09
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 160 mg
Subject Pitavastatin Small molecule 2 mg

Indications

No indication recorded.